
Aim: To measure the awareness of the general public about Systemic Lupus Erythmatosus, its clinical manifestations, treatment, consequences and co-morbidities. Objective: To assess the the awareness of the general public about Systemic Lupus Erythmatosus and its clinical manifestations. To assess the treatment, consequences and co-morbidities on Systemic Lupus Erythematosus. Background: Systemic Lupus Erythmatosus (SLE) is one of the autoimmune disease which is characterized by the presence of autoantibodies directed against nuclear antigens. It is known as multi-system disease, cause it can lead to multiple organ failure. Thus, it is important to know the onset and have early diagnosis on it, in order to prevent it from becoming more severe. There are various symptoms which SLE can develop, such as fatigue, fever and joint problem. The most common symptoms are joint swelling as well as butterfly rashes, which are commonly experienced by female patients. The prevalence of SLE is varies, but it is estimated to be 1 per 1000 overall with a female to male ratio of 10:1. Management of this disease should include both pharmacological and non-pharmacological modalities for symptomatic relieved and to improved quality of life.